Crossfund Sicav-Cross.M&M.Eq.F.A/ LU2208087424 /
NAV6/19/2024 | Chg.+0.5100 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
93.2100CHF | +0.55% | reinvestment | Equity Worldwide | FundPartner Sol.(EU) ▶ |
Monthly performance
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2021 | - | - | -0.14 | 4.89 | 1.55 | -4.05 | 4.87 | -0.58 | -3.48 | 3.74 | -1.11 | 1.99 | - |
2022 | -2.39 | 3.63 | 3.80 | -4.42 | 2.41 | -17.13 | 3.05 | -0.03 | -5.49 | 2.27 | 16.50 | -4.10 | -5.25% |
2023 | 10.17 | -8.91 | 0.15 | -1.68 | -7.65 | 5.31 | 4.93 | -9.81 | -3.14 | -8.71 | 5.98 | 8.39 | -7.60% |
2024 | -8.83 | -5.42 | 10.67 | 6.75 | 2.78 | -7.12 | - | - | - | - | - | - | - |
Calculated values
YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
---|---|---|---|---|---|
Volatility | 21.87% | 21.47% | 22.90% | 21.55% | -% |
Sharpe ratio | -0.44 | -0.41 | -0.63 | -0.30 | - |
Best month | +10.67% | +10.67% | +10.67% | +16.50% | - |
Worst month | -8.83% | -8.83% | -9.81% | -17.13% | - |
Maximum loss | -14.00% | -15.56% | -23.01% | -29.81% | - |
Outperformance | - | - | - | - | - |
All quotes in CHF
Share classes
Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
---|---|---|---|---|---|
Crossfund Sicav-Cross.M&M.Eq.F.A | reinvestment | 93.2100 | -10.75% | -8.21% | |
Crossfund Sicav-Cross.M&M.Eq.F.A | reinvestment | 97.4300 | -8.57% | -5.30% | |
Crossfund Sicav-Cross.M&M.Eq.F.A | reinvestment | 106.0800 | -6.16% | +2.60% | |
Crossfund Sicav-Cross.M&M.Eq.F.D | reinvestment | 100.3600 | -5.31% | - |
Performance
YTD | -2.75% | ||
---|---|---|---|
6 Months | -2.52% | ||
1 Year | -10.75% | ||
3 Years | -8.21% | ||
5 Years | - | ||
10 Years | - | ||
Since start | -8.93% | ||
Year | |||
2023 | -7.60% | ||
2022 | -5.25% |